The Ministry of Health of Corientes repairs a strategy of primary health care (PHC) for patients at risk that will start in the second week of February in different parts of the province.
Functions include health agent, health promoter and obstetrician they will go door to door to detect diseases in a certain neighborhood such as diabetes, high blood pressure and various types of cancer and pregnancy and thus enter the health system.
it will start first In the capital, Saladas, Empedrado, Virrasoro, Esquina and Paso de los Libres , together and then it will be extended to others. Each location will be staffed for a full week, he explained to the health ministry.
The greeting minister said, “The idea is to mobilize all primary care resources from the ministry and various hospitals and go to the neighborhoods of the capital and the different departments of the province to look for vulnerable people.” Ricardo Cardozo.
“We are planning to start the second week of February and we are going to do it in a neighborhood of the capital, which is esperanza And at the same time we will be in Saladas, Empedrado, Esquina, Paso de los Libres and Verasoro”, he said.
In addition, Cardozo explained: “Work will be done to detect chronic non-communicable diseases such as diabetes, hypertension, various cancers and pregnant women. These people will be traced and the information will be loaded into a system that will track their will guide Which doctor’s office, which line of care they will be assigned for check-up and related studies and, in turn, there will be a call center that will control that these tasks are carried out”.
The minister remarked that “this is very important because many people do not know that they are at risk. So the idea is to go directly to the homes of these patients so that they can be included in the health system.
Along with this, he also gave an example of the importance of homework. He added: “In 2022, around 100 health promoters in the capital visited 79,000 people and from there we have identified many at-risk patients who have been treated, studied and followed up clinically during this period. We’re talking about cancer, diabetes and high blood pressure.